Data / Research funding / Polycystic Ovary Syndrome (PCOS)
Polycystic Ovary Syndrome (PCOS): 45 NIH awards ($41.7M) to 25 organizations
45 NIH awards ($41.7M) in the NIH spending category Polycystic Ovary Syndrome (PCOS), to 25 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
45 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Elucidating the Genetic Architecture of Metabolic and Reproductive PCOS Subtypes in Diverse Populations | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,703,047 | August 1, 2020 | May 31, 2026 | DUNAIF, ANDREA E | reporter.nih.gov |
| AMH signaling pathway variation in PCOS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,442,460 | June 1, 2020 | February 28, 2026 | URBANEK, MARGRIT | reporter.nih.gov |
| Glycemic reduction approaches in polycystic ovary syndrome: a comparative effectiveness study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,399,124 | December 15, 2021 | November 30, 2026 | SASLOW, LAURA | reporter.nih.gov |
| Development of the GnRH neuronal network and effects of prenatal androgen exposure | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,166,674 | May 1, 2021 | January 31, 2027 | MOENTER, SUZANNE M | reporter.nih.gov |
| Multigenerational Effects of Gestational Testosterone Excess | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,083,543 | June 1, 2020 | May 31, 2026 | PADMANABHAN, VASANTHA | reporter.nih.gov |
| Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,051,810 | September 1, 2023 | June 30, 2028 | SARKAR, MONIKA | reporter.nih.gov |
| Developmental Origins of Polycystic Ovary Syndrome: Very Early Phenotypes During the Mini Puberty of Infancy and Beyond | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,860,791 | June 1, 2022 | February 29, 2028 | TORCHEN, LAURA C | reporter.nih.gov |
| Climate factors, racial/ethnic disparities, and menstrual cycle health | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,670,077 | April 1, 2023 | January 31, 2028 | MAHALINGAIAH, SHRUTHI | reporter.nih.gov |
| Role of semaglutide in restoring ovulation in youth and adults with polycystic ovary syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,596,199 | August 15, 2023 | July 31, 2028 | CREE, MELANIE G | reporter.nih.gov |
| Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,550,613 | August 1, 2019 | July 31, 2025 | CREE, MELANIE G | reporter.nih.gov |
| The interaction of basal risk, pharmacologic ovulation induction, pregnancy and delivery on hemostatic balance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,466,968 | April 1, 2018 | March 31, 2024 | BERNSTEIN, IRA MARK | reporter.nih.gov |
| Inositol Supplementation to Treat Reproductive and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Double Blind RCT (INSUPP-PCOS) | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $1,457,355 | September 1, 2018 | August 31, 2025 | LEGRO, RICHARD S. | reporter.nih.gov |
| Role of the Gut Microbiome in Polycystic Ovary Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,380,945 | February 15, 2019 | January 31, 2025 | THACKRAY, VARYKINA G | reporter.nih.gov |
| Role of obesity in blood pressure regulation and insulin resistance in Polycystic Ovary Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,368,130 | December 1, 2023 | November 30, 2028 | YANES CARDOZO, LICY LORENA | reporter.nih.gov |
| Gestational Hyperandrogenism in Cardiovascular Programming | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,194,769 | September 4, 2020 | August 31, 2025 | VYAS, ARPITA | reporter.nih.gov |
| Resistant starch treatment of polycystic ovary syndrome: impact on cardiometabolic dysfunction and the gut microbiome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $998,708 | September 1, 2024 | May 31, 2028 | DOKRAS, ANUJA | reporter.nih.gov |
| Novel Aspect of Androgen Action in Ovarian Cell Function and Dysfunction | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $981,658 | September 1, 2019 | May 31, 2025 | RICHARDS, JOANNE STEWART | reporter.nih.gov |
| ROLE OF ANDROGENS IN THE NEUROENDOCRINE DYSFUNCTION OF NASCENT PCOS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $961,888 | September 25, 2019 | March 31, 2025 | BURT SOLORZANO, CHRISTINE MICHELE | reporter.nih.gov |
| Relevance of polycystic ovarian morphology in the clinical evaluation of PCOS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $936,312 | August 28, 2018 | May 31, 2025 | LUJAN, MARLA E | reporter.nih.gov |
| The Role of Energy Balance in Gonadotrope and Reproductive Function | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $816,116 | July 1, 2021 | June 30, 2024 | NICHOLAS, DEQUINA ANGELINA | reporter.nih.gov |
| Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort | NIH | National Heart, Lung, and Blood Institute | 2023 | $761,272 | September 23, 2023 | August 31, 2025 | KIM, CATHERINE | reporter.nih.gov |
| Gestational Hyperandrogenism in Cardiovascular Programming | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $738,830 | September 4, 2020 | September 30, 2022 | VYAS, ARPITA | reporter.nih.gov |
| Emergence of polycystic ovary syndrome (PCOS) during adolescence | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $695,541 | August 1, 2025 | April 30, 2030 | LUJAN, MARLA E | reporter.nih.gov |
| The role of Kisspeptin/Neurokinin B/Dynorphin (KNDy) neurons in the pathogenesis of polycystic ovarian syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $689,143 | September 4, 2018 | March 31, 2024 | MOORE, ALEISHA | reporter.nih.gov |
| Peer specialist intervention to improve mental health among women with Polycystic Ovarian Syndrome and other patients receiving hormonal care | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $678,240 | January 17, 2022 | November 30, 2026 | STROUMSA, DAPHNA | reporter.nih.gov |
| The Role of Kisspeptin/Neurokinin B/Dynorphin (KNDy) neurons in an animal model of polycystic ovary syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $653,600 | August 19, 2024 | May 31, 2029 | MOORE, ALEISHA | reporter.nih.gov |
| Dopaminergic Regulation of KNDy Neurons: Implications for GnRH Pulses and PCOS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $624,809 | June 1, 2025 | March 31, 2030 | NAVARRO, VICTOR MANUEL | reporter.nih.gov |
| Investigating the impact of physical activity in modulating PCOS risk among peripubertal females | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $578,336 | January 1, 2023 | November 30, 2027 | WHOOTEN, RACHEL | reporter.nih.gov |
| The presentation and medical course of PCOS in adolescents across the United States | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $556,073 | June 5, 2023 | May 31, 2026 | CREE, MELANIE G | reporter.nih.gov |
| Genetic Dissection of the Pathophysiology of Polycystic Ovary Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $503,820 | September 1, 2023 | August 31, 2028 | ZHU, JIA | reporter.nih.gov |
| Paxillin and Androgens in the Regulation of Ovarian Follicle Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $472,040 | September 1, 2022 | August 31, 2025 | ASTAPOVA, OLGA | reporter.nih.gov |
| SMAD5 signaling in Polycystic Ovary Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $440,000 | August 1, 2024 | July 31, 2026 | PANGAS, STEPHANIE A. | reporter.nih.gov |
| Pathophysiology and therapeutic strategy for late reproductive aged women with PCOS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $377,064 | May 1, 2019 | August 31, 2023 | KIM, SU H. | reporter.nih.gov |
| A metabolomics-based laboratory developed test to improve the diagnostic precision of Polycystic Ovary Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $297,666 | September 18, 2023 | August 31, 2024 | KENNEDY, ADAM DAVID | reporter.nih.gov |
| Adipokine-enriched brown adipocytes for treating polycystic ovary syndromes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $256,580 | September 19, 2022 | August 31, 2023 | LIU, YONGXING "JAMES" | reporter.nih.gov |
| Artificial intelligence for the automated detection of polycystic ovary syndrome on ultrasonography | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $245,157 | August 1, 2025 | July 31, 2027 | LUJAN, MARLA E | reporter.nih.gov |
| Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $242,250 | February 15, 2022 | July 31, 2024 | SARKAR, MONIKA | reporter.nih.gov |
| Effects of Maternal Genetic Risk Factors for Polycystic Ovary Syndrome on Birth and Childhood Outcomes in Offspring | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $178,000 | May 9, 2025 | April 30, 2027 | ZHU, JIA | reporter.nih.gov |
| Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $162,500 | May 15, 2022 | March 31, 2025 | DOKRAS, ANUJA | reporter.nih.gov |
| Dissecting PCOS Physiology by Defining Phenotypes Associated with PCOS Genetic Risk Factors in Men and Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $158,436 | July 1, 2021 | June 30, 2023 | ZHU, JIA | reporter.nih.gov |
| Effects of development and prenatal androgen exposure on GnRH neuron intrinsic properties | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $76,968 | September 1, 2022 | July 2, 2024 | JAIME, JENNIFER | reporter.nih.gov |
| Impact of SGLT-2 Inhibition on the Cardiometabolic Profile of PCOS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $76,498 | March 1, 2021 | February 28, 2023 | PRUETT, JACOB E | reporter.nih.gov |
| Androgen Excess Polycystic Ovary Syndrome Society Meeting | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $50,000 | January 15, 2017 | March 31, 2026 | DOKRAS, ANUJA | reporter.nih.gov |
| Effect of surgical and pharmacological obesity treatments on hepatic fat, energy flux, and mitochondria | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $48,815 | July 1, 2023 | February 7, 2024 | FULLER, KELLY | reporter.nih.gov |
| The effect of gonadotropin pathway genetic variation on PCOS pathogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $44,187 | January 1, 2025 | December 31, 2027 | STOKES, GIANGELA MARIA | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 19 | $7,354,386 | 0 | $0 |
| 2024 | 19 | $7,561,630 | 0 | $0 |
| 2023 | 29 | $10,411,715 | 0 | $0 |
| 2022 | 27 | $9,112,130 | 0 | $0 |
| 2021 | 18 | $7,253,151 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.